Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 Jun 2024
Historique:
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 18 6 2024
Statut: epublish

Résumé

Gaps in antimicrobial resistance (AMR) surveillance and control, including implementation of national action plans (NAPs), are evident internationally. Countries' capacity to translate political commitment into action is crucial to cope with AMR at the human-animal-environment interface. We employed a two-stage process to understand opportunities and challenges related to AMR surveillance and control at the human-animal interface in Argentina. First, we compiled the central AMR policies locally and mapped vital stakeholders around the NAP and the national commission against bacterial resistance. Second, we conducted qualitative interviews using a semistructured questionnaire covering stakeholders' understanding and progress towards AMR and NAP. We employed a mixed deductive-inductive approach and used the constant comparative analysis method. We created categories and themes to cluster subthemes and determined crucial relationships among thematic groups. Crucial AMR policy developments have been made since 1969, including gradually banning colistin in food-producing animals. In 2023, a new government decree prioritised AMR following the 2015 NAP launch. Our qualitative analyses identified seven major themes for tackling AMR: (I) Cultural factors and sociopolitical country context hampering AMR progress, (II) Fragmented governance, (III) Antibiotic access and use, (IV) AMR knowledge and awareness throughout stakeholders, (V) AMR surveillance, (VI) NAP efforts and (VII) External drivers. We identified a fragmented structure of the food production chain, poor cross-coordination between stakeholders, limited surveillance and regulation among food-producing animals and geographical disparities over access, diagnosis and treatment. The country is moving to integrate animal and food production into its surveillance system, with most hospitals experienced in monitoring AMR through antimicrobial stewardship programmes. AMR accountability should involve underpinning collaboration at different NAP implementation levels and providing adequate resources to safeguard long-term sustainability. Incorporating a multisectoral context-specific approach relying on different One Health domains is crucial to strengthening local AMR surveillance.

Identifiants

pubmed: 38889938
pii: bmjopen-2023-082156
doi: 10.1136/bmjopen-2023-082156
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e082156

Investigateurs

Rodolfo Luzbel de la Sota (RL)
Sonia Gómez (S)
Sergio Sánchez Bruni (SS)
Kristen Reyher (K)
Helen West (H)
Peers Davies (P)
Dominic Moran (D)

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kasim Allel (K)

Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
Heatlh Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxfordshire, UK.

Mariano Fernandez-Miyakawa (M)

Instituto Nacional de Tecnología Agropecuaria, Buenos Aires, Argentina.

William Gaze (W)

Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.

Alejandro Petroni (A)

Instituto Nacional de Enfermedades Infecciosas, Buenos Aires, Argentina.

Alejandra Corso (A)

Instituto Nacional de Enfermedades Infecciosas, Buenos Aires, Argentina.

Federico Luna (F)

Independent Researcher, Buenos Aires, Argentina.

Laura Barcelona (L)

Comisión Nacional de Control de la Resistencia Antimicrobiana, Buenos Aires, Argentina.

Lisa Boden (L)

University of Edinburgh Royal Dick School of Veterinary Studies, Easter Bush Campus, Midlothian, UK.

Emma Pitchforth (E)

Faculty of Health and Life Sciences, University of Exeter, Exeter, UK e.pitchforth@exeter.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH